| Stage | CRK | % of rev | EOG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $353M | 100.00% | $8.6B | 100.00% | EOG ×24.24 |
| Gross profit | $310M | 87.73% | $7.4B | 86.65% | CRK +1.1pp |
| Operating income | $23M | 6.39% | $3.5B | 41.21% | EOG +34.8pp |
| Pre-tax income | $12M | 3.44% | $3.5B | 40.87% | EOG +37.4pp |
| Net income | $15M | 4.25% | $2.7B | 31.81% | EOG +27.6pp |
| Stage | CRK | EOG | Gap · A − B |
|---|---|---|---|
| Revenue | $353M100.00% | $8.6B100.00% | EOG ×24.24 |
| Gross profit | 87.73%$310M | 86.65%$7.4B | CRK +1.1pp |
| Operating income | 6.39%$23M | 41.21%$3.5B | EOG +34.8pp |
| Pre-tax income | 3.44%$12M | 40.87%$3.5B | EOG +37.4pp |
| Net income |
| 4.25%$15M |
| 31.81%$2.7B |
| EOG +27.6pp |
No shared counterparties.